KAYLA JONES: Open Payments
NPI 1750853271 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 54 payments from 18 companies in 2025. Trend: 2023 $1,629 · 2024 $1,432 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $149 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Madrigal Pharmaceuticals | 3 | $83 |
| Janssen Biotech, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Gilead Sciences, Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $30 |
Products named: ENTYVIO, NUZYRA, SKYRIZI, XIFAXAN, REZDIFFRA, TREMFYA, LINZESS, CREON.
Industry payments across GA — which companies pay providers there.
